Skip to main content

Table 3 Relationship between Change in CA125 and Covariates

From: Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer

Variable

Change in CA125 from Baseline to 3 months N (%)

P

 

Normal to Normal

High to Normal

Normal to High

High to High

 

Prior Treatment History

     

   • Previously treated disease

15 (60)

17 (50)

6 (100)

96 (91.4)

<0.001 (chi-square)

   • Newly diagnosed

10 (40)

17 (50)

0 (0)

9 (8.6)

 

Stage at Diagnosis

     

   • Stage I

10 (40)

4 (14.3)

0 (0)

11 (10.9)

 

   • Stage II

2 (8)

6 (21.4)

0 (0)

7 (6.9)

0.009 (chi- square)

   • Stage III

11 (44)

15 (53.6)

5 (83.3)

75 (74.3)

 

   • Stage IV

2 (8)

3 (10.7)

1 (16.7)

8 (7.9)

 
 

Mean (Standard Deviation)

 

Age at presentation

52.3 (12.9)

55.4 (11.5)

54.1 (6.3)

52.9 (10.2)

0.67 (ANOVA)